Skip to content

Ultrasound-Guided Transforaminal Epidural Injection with Fluoroscopy Confirmation for the Treatment of Unilateral Lumbar Radiculopathy: A Randomized Controlled Non-Inferiority Study

Ultrasound-Guided Transforaminal Epidural Injection with Fluoroscopy Confirmation for the Treatment of Unilateral Lumbar Radiculopathy: A Randomized Controlled Non-Inferiority Study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100054668
Enrollment
Unknown
Registered
2021-12-23
Start date
2021-11-01
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbar radiculopathy

Interventions

Experimental group1:lumber TFSI under US guidance verified by fluoroscopic
Experimental group2:lumber TFSI under fluoroscopy guidance

Sponsors

Xuanwu Hospital of Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. The clinical manifestation is lower extremity sciatica, which is confirmed by fluoroscopy and magnetic resonance examination as lumbar disc herniation or intervertebral foramen stenosis; 2. Numerical Rating Scale (NRS) of pain level >= 4; 3. LRP may originate in one or two lumbar spine segments; 4. Conservative treatment is ineffective, and the course of the disease lasts for more than 3 months; 5. Aged >=18 years; 6. Willingness to complete assigned treatment and follow-up assessments.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal cardiopulmonary function and coagulation dysfunction; 2. Mental problems; 3. Hypersensitivity to lidocaine, glucocorticoids or contrast agents; 4. Systemic use of corticosteroids; 5. History of previous lumbar spine surgery; 6. Have a history of lumbar epidural injection within 3 months; 7. Local skin infection; 8. Pregnancy etc. were excluded from the study.

Design outcomes

Primary

MeasureTime frame
excellent rate of contrast distribution;

Secondary

MeasureTime frame
puncture time;

Countries

China

Contacts

Public ContactYang Liqiang

Xuanwu Hospital of Capital Medical University

ylqpainmanagement@163.com+86 13601180073

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026